U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Urethral Urothelial Carcinoma

MedGen UID:
1382493
•Concept ID:
C0862468
•
Neoplastic Process
Synonym: Recurrent Urothelial Carcinoma of the Urethra

Definition

The reemergence of urethral urothelial carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Urethral Urothelial Carcinoma

Professional guidelines

PubMed

Management of Urethral Recurrences: Urothelial and Nonurothelial.
Zargar-Shoshtari K, Sexton WJ, Poch MA
Urol Clin North Am 2016 Nov;43(4):515-521. doi: 10.1016/j.ucl.2016.06.012. PMID: 27717437
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management.
Chan Y, Fisher P, Tilki D, Evans CP
BJU Int 2016 Apr;117(4):563-9. Epub 2015 Dec 12 doi: 10.1111/bju.13370. PMID: 26556525
Diagnosis and management of urothelial carcinoma of the bladder.
Tanaka MF, Sonpavde G
Postgrad Med 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. PMID: 21566415

Recent clinical studies

Etiology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG
Eur Urol 2024 Jan;85(1):17-31. Epub 2023 Oct 17 doi: 10.1016/j.eururo.2023.08.016. PMID: 37858453
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN
Lancet Oncol 2021 Jan;22(1):107-117. Epub 2020 Nov 27 doi: 10.1016/S1470-2045(20)30540-4. PMID: 33253641Free PMC Article
Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis.
Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Kübler H, Stenzl A, Gakis G
Urol Oncol 2018 Feb;36(2):54-59. Epub 2017 Nov 28 doi: 10.1016/j.urolonc.2017.11.007. PMID: 29196179
The microbiome of the urinary tract--a role beyond infection.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP
Nat Rev Urol 2015 Feb;12(2):81-90. Epub 2015 Jan 20 doi: 10.1038/nrurol.2014.361. PMID: 25600098
Diagnosis and management of urothelial carcinoma of the bladder.
Tanaka MF, Sonpavde G
Postgrad Med 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. PMID: 21566415

Diagnosis

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG
Eur Urol 2024 Jan;85(1):17-31. Epub 2023 Oct 17 doi: 10.1016/j.eururo.2023.08.016. PMID: 37858453
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA
J Natl Compr Canc Netw 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. PMID: 35948037
Novel Noninvasive Diagnostics.
Wiley C, Wise CF, Breen M
Vet Clin North Am Small Anim Pract 2019 Sep;49(5):781-791. Epub 2019 Jul 4 doi: 10.1016/j.cvsm.2019.05.002. PMID: 31280902
Management of Urethral Recurrences: Urothelial and Nonurothelial.
Zargar-Shoshtari K, Sexton WJ, Poch MA
Urol Clin North Am 2016 Nov;43(4):515-521. doi: 10.1016/j.ucl.2016.06.012. PMID: 27717437
The microbiome of the urinary tract--a role beyond infection.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP
Nat Rev Urol 2015 Feb;12(2):81-90. Epub 2015 Jan 20 doi: 10.1038/nrurol.2014.361. PMID: 25600098

Therapy

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN
Lancet Oncol 2021 Jan;22(1):107-117. Epub 2020 Nov 27 doi: 10.1016/S1470-2045(20)30540-4. PMID: 33253641Free PMC Article
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management.
Chan Y, Fisher P, Tilki D, Evans CP
BJU Int 2016 Apr;117(4):563-9. Epub 2015 Dec 12 doi: 10.1111/bju.13370. PMID: 26556525
The microbiome of the urinary tract--a role beyond infection.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP
Nat Rev Urol 2015 Feb;12(2):81-90. Epub 2015 Jan 20 doi: 10.1038/nrurol.2014.361. PMID: 25600098
Diagnosis and management of urothelial carcinoma of the bladder.
Tanaka MF, Sonpavde G
Postgrad Med 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. PMID: 21566415
Superficial bladder cancer therapy.
Schenkman E, Lamm DL
ScientificWorldJournal 2004 Jun 28;4 Suppl 1:387-99. doi: 10.1100/tsw.2004.81. PMID: 15349563Free PMC Article

Prognosis

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG
Eur Urol 2024 Jan;85(1):17-31. Epub 2023 Oct 17 doi: 10.1016/j.eururo.2023.08.016. PMID: 37858453
Clinical features and oncological outcomes of primary female urethral cancer.
Lee W, Yu J, Lee JL, Kim YS, Hong B
J Surg Oncol 2022 Apr;125(5):907-915. Epub 2022 Jan 20 doi: 10.1002/jso.26790. PMID: 35050502
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN, Kassouf W
Eur Urol 2017 Apr;71(4):545-557. Epub 2016 Oct 6 doi: 10.1016/j.eururo.2016.09.035. PMID: 27720534Free PMC Article
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management.
Chan Y, Fisher P, Tilki D, Evans CP
BJU Int 2016 Apr;117(4):563-9. Epub 2015 Dec 12 doi: 10.1111/bju.13370. PMID: 26556525
The microbiome of the urinary tract--a role beyond infection.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP
Nat Rev Urol 2015 Feb;12(2):81-90. Epub 2015 Jan 20 doi: 10.1038/nrurol.2014.361. PMID: 25600098

Clinical prediction guides

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG
Eur Urol 2024 Jan;85(1):17-31. Epub 2023 Oct 17 doi: 10.1016/j.eururo.2023.08.016. PMID: 37858453
Clinical features and oncological outcomes of primary female urethral cancer.
Lee W, Yu J, Lee JL, Kim YS, Hong B
J Surg Oncol 2022 Apr;125(5):907-915. Epub 2022 Jan 20 doi: 10.1002/jso.26790. PMID: 35050502
Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature.
Foerster B, D'Andrea D, Abufaraj M, Broenimann S, Karakiewicz PI, Rouprêt M, Gontero P, Lerner SP, Shariat SF, Soria F
Urol Oncol 2019 Jul;37(7):430-436. Epub 2019 Mar 4 doi: 10.1016/j.urolonc.2019.02.004. PMID: 30846387
The microbiome of the urinary tract--a role beyond infection.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP
Nat Rev Urol 2015 Feb;12(2):81-90. Epub 2015 Jan 20 doi: 10.1038/nrurol.2014.361. PMID: 25600098
Photodynamic diagnosis in urology: state-of-the-art.
Jocham D, Stepp H, Waidelich R
Eur Urol 2008 Jun;53(6):1138-48. Epub 2007 Dec 10 doi: 10.1016/j.eururo.2007.11.048. PMID: 18096307

Recent systematic reviews

Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis.
Kawada T, Laukhtina E, Quhal F, Yanagisawa T, Rajwa P, Pallauf M, von Deimling M, Bianchi A, Pradere B, Fajkovic H, Enikeev D, Gontero P, Rouprêt M, Seisen T, Araki M, Shariat SF
Eur Urol Focus 2023 Mar;9(2):236-240. Epub 2022 Nov 30 doi: 10.1016/j.euf.2022.11.016. PMID: 36463089
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.
Laukhtina E, Moschini M, Soria F, Andrea DD, Teoh JY, Mori K, Albisinni S, Mari A, Krajewski W, Cimadamore A, Abufaraj M, Enikeev D, Neuzillet Y, Giannarini G, Xylinas E, Kamat AM, Roupret M, Babjuk M, Witjes JA, Shariat SF, Pradere B; European Association of Urology; Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group; European Association of Urology Section of Oncological Urology ESOU
Eur Urol Focus 2022 Nov;8(6):1635-1642. Epub 2022 Mar 23 doi: 10.1016/j.euf.2022.03.004. PMID: 35337773
Ureteral and urethral recurrence after radical cystectomy: a systematic review.
Carando R, Shariat SF, Moschini M, D'Andrea D
Curr Opin Urol 2020 May;30(3):441-448. doi: 10.1097/MOU.0000000000000752. PMID: 32235282
Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis.
Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Kübler H, Stenzl A, Gakis G
Urol Oncol 2018 Feb;36(2):54-59. Epub 2017 Nov 28 doi: 10.1016/j.urolonc.2017.11.007. PMID: 29196179
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN, Kassouf W
Eur Urol 2017 Apr;71(4):545-557. Epub 2016 Oct 6 doi: 10.1016/j.eururo.2016.09.035. PMID: 27720534Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...